Determination of lesinurad in rat plasma by a UHPLC–MS/MS assay

Lesinurad is an oral inhibitor of urate-anion exchanger transporter 1 and has been approved by the US Food and Drug Administration for combination therapy with a xanthine oxidase inhibitor for the treatment of hyperuricemia associated with refractory gout. In the present study, a sensitive and speci...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xiao-Yang, Yuan, Ling-Jing, Chen, Zhe, Tang, Peng-Fei, Li, Xiang-Yu, Hu, Guo-Xin, Cai, Jian-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704027/
https://www.ncbi.nlm.nih.gov/pubmed/29181594
http://dx.doi.org/10.1186/s13065-017-0353-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704027/
https://www.ncbi.nlm.nih.gov/pubmed/29181594
http://dx.doi.org/10.1186/s13065-017-0353-6

Ejemplares similares